Obio Technology (Shanghai) Corp., Ltd. (SHA:688238)
7.76
+0.14 (1.84%)
At close: Sep 29, 2025
SHA:688238 Revenue
Obio Technology (Shanghai) Corp. had revenue of 67.01M CNY in the quarter ending June 30, 2025, with 25.28% growth. This brings the company's revenue in the last twelve months to 254.94M, up 8.90% year-over-year. In the year 2024, Obio Technology (Shanghai) Corp. had annual revenue of 248.15M with 21.16% growth.
Revenue (ttm)
254.94M
Revenue Growth
+8.90%
P/S Ratio
19.46
Revenue / Employee
376.02K
Employees
692
Market Cap
4.96B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 248.15M | 43.34M | 21.16% |
Dec 31, 2023 | 204.81M | -86.50M | -29.69% |
Dec 31, 2022 | 291.30M | 36.36M | 14.26% |
Dec 31, 2021 | 254.95M | 112.18M | 78.57% |
Dec 31, 2020 | 142.77M | 79.85M | 126.93% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Jiangsu Hengrui Medicine | 30.15B |
WuXi AppTec | 41.90B |
Shenzhen Mindray Bio-Medical Electronics | 32.94B |
Sichuan Biokin Pharmaceutical | 441.19M |
Shanghai United Imaging Healthcare | 10.98B |
Zhangzhou Pientzehuang Pharmaceutical., | 10.52B |
Aier Eye Hospital Group | 21.94B |
Yunnan Baiyao Group Co.,Ltd | 40.84B |